Insider Shareholders with Direct Ownership of Immunovant, Inc. (IMVT)
This section provides a comprehensive overview of the insiders with direct ownership of Immunovant, Inc. (IMVT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Immunovant, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 40,282,953 | 0 | 96,650,341 $2.66 Billion | 4 |
Jan 13, 2025
Added 14.84%
|
|
|
Peter Salzmann
Chief Executive Officer |
1,558,743 | 594,518 | 964,225 $26.5 Million | 35 |
Jan 15, 2025
Reduced 0.04%
|
|
Frank Torti
Director |
607,274 | 0 | 635,674 $17.5 Million | 6 |
Apr 02, 2024
Added 15.92%
|
|
Julia G. Butchko
Chief Development Officer |
607,788 | 171,829 | 440,959 $12.1 Million | 28 |
Aug 21, 2024
Reduced 0.03%
|
|
William L. Macias
Chief Medical Officer |
479,611 | 120,203 | 359,408 $9.89 Million | 25 |
Jan 15, 2025
Reduced 0.01%
|
|
Eva Renee Barnett
Chief Financial Officer |
457,958 | 133,192 | 324,766 $8.93 Million | 26 |
Jan 15, 2025
Reduced 0.03%
|
|
Mark S. Levine
Chief Legal Officer |
398,458 | 79,230 | 319,228 $8.78 Million | 21 |
Nov 20, 2024
Reduced 1.13%
|
|
Jay S Stout
Chief Technology Officer |
154,978 | 14,987 | 139,991 $3.85 Million | 6 |
Jan 22, 2025
Reduced 1.54%
|
|
Michael Geffner
Chief Medical Officer |
54,978 | 22,664 | 132,314 $3.64 Million | 6 |
Jan 22, 2025
Reduced 1.97%
|
|
Rita Jain
Chief Medical Officer |
129,365 | 0 | 129,365 $3.56 Million | 2 |
Mar 19, 2021
Added 45.81%
|
|
George V Migausky
Director |
89,063 | 12,700 | 121,063 $3.33 Million | 7 |
Apr 02, 2024
Added 8.51%
|
|
Douglas J. Hughes
Director |
100,310 | 5,425 | 119,585 $3.29 Million | 7 |
Dec 02, 2024
Reduced 4.34%
|
|
Melanie Gloria
Chief Operating Officer |
109,956 | 0 | 109,956 $3.02 Million | 1 |
Nov 18, 2024
Added 50.0%
|
|
Christopher Van Tuyl
Chief Legal Officer |
109,956 | 0 | 109,956 $3.02 Million | 1 |
Dec 16, 2024
Added 50.0%
|
|
Andrew J. Fromkin
Director |
87,563 | 12,350 | 99,913 $2.75 Million | 7 |
Apr 02, 2024
Added 10.12%
|
|
Michael James Elliott
Chief Scientific Officer |
97,600 | 0 | 97,600 $2.68 Million | 1 |
Mar 19, 2021
Added 50.0%
|
|
Atul Pande
Director |
82,063 | 20,100 | 86,663 $2.38 Million | 7 |
Dec 02, 2024
Reduced 8.21%
|
|
Connealy Pamela Yanchik
Chief Financial Officer |
46,200 | 0 | 46,200 $1.27 Million | 1 |
Mar 19, 2021
Added 50.0%
|